Theravance Biopharma
TBPH
#6917
Rank
€0.42 B
Marketcap
Country
8,53 €
Share price
-0.86%
Change (1 day)
2.00%
Change (1 year)
Categories
Operating Margin for Theravance Biopharma (TBPH)
Operating Margin as of March 2025 (TTM): -69.29%
According to Theravance Biopharma 's latest financial reports and stock price the company's current Operating Margin is -69.29%. At the end of 2024 the company had an Operating Margin of -65.34%.
Operating Margin history for Theravance Biopharma from 2013 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -65.34% | -20.03% |
| 2023 | -81.71% | -51.47% |
| 2022 | -168.36% | -63.72% |
| 2021 | -464.06% | 13.11% |
| 2020 | -410.25% | 43.55% |
| 2019 | -285.80% | -19.98% |
| 2018 | -357.14% | -79.12% |
| 2017 | -1,710.41% | 364.45% |
| 2016 | -368.27% | -14.42% |
| 2015 | -430.30% | -78.2% |
| 2014 | -1,973.60% | -97.15% |
| 2013 | -69,152.21% | 939828.43% |
| 2012 | -7.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 27.32% | -139.43% | 🇺🇸 USA |
 | 23.92% | -134.52% | 🇺🇸 USA |
 | 43.97% | -163.46% | 🇺🇸 USA |
 | -2.05% | -97.04% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.